Company news
Alector, Inc. news in 2025
Alector, Inc.'s news releases, calls and decks from 2025, newest first.
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer
December 11, 2025
Alector to Participate in the Bank of America CNS Therapeutics Conference
November 30, 2025
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
November 5, 2025
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update
October 20, 2025
Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs
September 15, 2025
Alector to Participate in Upcoming Healthcare Conferences
August 27, 2025
Alector Reports Second Quarter 2025 Financial Results and Provides Business Update
August 6, 2025
Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call
July 30, 2025
Alector Provides Executive Leadership Update
June 12, 2025
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 2, 2025
Alector Reports First Quarter 2025 Financial Results and Provides Business Update
May 7, 2025
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
April 16, 2025
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 25, 2025
Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call
February 18, 2025
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025
January 12, 2025
Calls in 2025
Decks in 2025
- The 7th CNS Drug Delivery Summit (December 2025)
Conference · 24 slides · Dec 11, 2025
- Technical Presentation (September 2025)
Technical · 55 slides · September 2025